A novel cervix carcinoma biomarker: Pathological-epigenomics, integrated analysis of MethylMix algorithm and pathology for predicting response to cancer immunotherapy
Herein, A non-invasive pathomics approach was developed to reveal the methylation status in patients with cervical squamous cell carcinoma and predict clinical outcomes and treatment response. Using the MethylMix algorithm, 14 methylation-driven genes were selected for further analysis. We confirmed...
Main Authors: | Yu-Chong Yu, Tian-Ming Shi, Sheng-Lan Gu, Yu-Hong Li, Xiao-Ming Yang, Qiong Fan, Yu-Dong Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.1053800/full |
Similar Items
-
Development and validation of a radiopathomic model for predicting pathologic complete response to neoadjuvant chemotherapy in breast cancer patients
by: Jieqiu Zhang, et al.
Published: (2023-05-01) -
Development and Validation of a Pathomics Model Using Machine Learning to Predict Expression and Prognosis in Head and Neck Cancer
by: Weihua Wang, et al.
Published: (2024-02-01) -
Multimodal data integration for predicting progression risk in castration-resistant prostate cancer using deep learning: a multicenter retrospective study
by: Chuan Zhou, et al.
Published: (2024-03-01) -
From pixels to patient care: deep learning-enabled pathomics signature offers precise outcome predictions for immunotherapy in esophageal squamous cell cancer
by: Butuo Li, et al.
Published: (2024-02-01) -
Relationship between the deep features of the full-scan pathological map of mucinous gastric carcinoma and related genes based on deep learning
by: Ding Li, et al.
Published: (2023-03-01)